Amitifadine
id:
amitifadine-171-5805749
title:
Amitifadine
text:
Amitifadine is a serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI) or so-called triple reuptake inhibitor (TRI) which is or was being developed by Euthymics Bioscience. It was under development for the treatment of major depressive disorder, but in May 2013, it was reported that the drug failed to show superior efficacy to placebo in a phase IIb/IIIa clinical trial. it was suggested that this may have been due to the drug being underdosed. In September 2017, development of amitifadine
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Amitifadine
date created:
2011-08-05T08:21:00Z
date modified:
2024-09-01T11:09:28Z
main entity:
{"identifier":"Q2843568","url":"https://www.wikidata.org/entity/Q2843568"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/a/a7/Amitifadine.svg","width":512,"height":404}
fields total:
13
integrity:
16